CAS 38916-34-6
:somatostatine
Description :
somatostatine est une hormone peptidique composée de 14 acides aminés, principalement connue pour son rôle dans l'inhibition de la sécrétion de plusieurs autres hormones, y compris l'hormone de croissance et l'insuline. Elle est produite dans divers tissus, notamment l'hypothalamus et le tractus gastro-intestinal. somatostatine fonctionne comme une hormone régulatrice, jouant un rôle crucial dans le système endocrinien en modulant l'activité d'autres hormones et neurotransmetteurs. Son numéro CAS, 38916-34-6, l'identifie de manière unique dans les bases de données chimiques. La substance se caractérise par sa demi-vie relativement courte dans la circulation, nécessitant une administration prudente dans des contextes thérapeutiques. Les analogues de somatostatine sont souvent utilisés dans des contextes cliniques pour gérer des conditions telles que l'acromégalie, certains types de tumeurs et des troubles gastro-intestinaux. Le peptide présente un haut degré de spécificité dans son action, se liant aux récepteurs de somatostatine, qui sont répartis dans tout le corps, influençant divers processus physiologiques. Dans l'ensemble, somatostatine est un composant vital de la régulation hormonale, avec des implications significatives tant pour la santé que pour la gestion des maladies.
Formule :C76H104N18O19S2
InChI :InChI=1/C76H104N18O19S2/c1-41(79)64(100)82-37-61(99)83-58-39-114-115-40-59(76(112)113)92-72(108)57(38-95)91-75(111)63(43(3)97)94-71(107)54(33-46-23-11-6-12-24-46)90-74(110)62(42(2)96)93-66(102)51(28-16-18-30-78)84-69(105)55(34-47-36-81-49-26-14-13-25-48(47)49)88-68(104)53(32-45-21-9-5-10-22-45)86-67(103)52(31-44-19-7-4-8-20-44)87-70(106)56(35-60(80)98)89-65(101)50(85-73(58)109)27-15-17-29-77/h4-14,19-26,36,41-43,50-59,62-63,81,95-97H,15-18,27-35,37-40,77-79H2,1-3H3,(H2,80,98)(H,82,100)(H,83,99)(H,84,105)(H,85,109)(H,86,103)(H,87,106)(H,88,104)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)
Synonymes :- 1: PN: US20020156010 PAGE: 3 unclaimed protein
- 15: PN: WO2007081792 SEQID: 30 claimed protein
- 15-28-Somatostatin-28
- 243: PN: EP1170021 SEQID: 2 claimed protein
- 34: PN: WO2007058336 SEQID: 34 claimed protein
- Cyclic growth hormone release-inhibiting hormone
- Cyclic ovine somatostatin
- Cyclic somatostatin
- Cyclic somatostatin-14
- Cyclic somatotropin release-inhibitor factor
- Cyclic tetradecapeptide somatostatin
- Lampetra fluviatilis somatostatin-14
- Somatostatin
- Somatostatin (Amphiuma tridactylum)
- Somatostatin (Anguilla anguilla)
- Somatostatin (Gopherus agassizii)
- Somatostatin (human)
- Somatostatin (Lophius americanus)
- Somatostatin (Myxine glutinosa)
- Somatostatin (pigeon)
- Somatostatin (rat)
- Somatostatin (sheep reduced), cyclic (3→14)-disulfide
- Somatostatin I (Lophius americanus)
- Somatostatin SS-14
- Somatostatin-14 (Gopherus agassizii)
- Somatostatin-14 (sheep)
- Somatostatina
- Somatostatine
- Sr 9357
- Sst 14
- Stilamin
- Synthetic cyclic growth hormone release-inhibiting factor
- Synthetic cyclic growth hormone release-inhibiting hormone
- Synthetic growth hormone release-inhibiting hormone
- Synthetic somatostatin-14
- Somatostatin 14
- Somatostatin Acetate
- somatostatin gamma-irradiated*cell culture tested
- H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond)
- alanyl-N-[19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10,16-bis(1-hydroxyethyl)-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl]glycinamide
- Voir plus de synonymes
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
13 produits concernés.
Somatostatin 14
CAS :<p>For cellular and molecular biology applications</p>Formule :C76H104N18O19S2Masse moléculaire :1637.89Somatostatin-14
CAS :Somatostatin-14 (SRIF) was originally isolated from ovine hypothalamic extracts on the basis of its ability to inhibit the secretion of radioimmunoassayable growth hormone by primary cultures of enzymatically dispersed rat anterior pituitary cells. SRIF is a small cyclic neuropeptide hormone with broad inhibitory effects on endocrine secretions such as the production of GH, glucagon, and insulin.Formule :C76H104N18O19S2Degré de pureté :99.7%Couleur et forme :White PowderMasse moléculaire :1637.9Somatostatin Acetate
CAS :Formule :C76H104N18O19S2Degré de pureté :95%~99%Couleur et forme :White to Off-white PowderMasse moléculaire :1637.88Somatostatin Acetate
CAS :<p>Applications Growth hormone-release inhibiting factor; treatment of severe, acute hemorrhage of gastroduodenal ulcers; experimental antidiabetic.<br>References Brazeau, P., et al.: Science, 179, 77 (1973), Siler, T.M., et al.: J. Clin. Endocrinol. Metab., 37, 632 (1973), Pradayrol, L., et al.: Biochem. Biophys. Res. Commun., 85, 701 (1978), Mandarino, L., et al.: Nature, 291, 76 (1981),<br></p>Formule :C78H108N18O21S2Couleur et forme :NeatMasse moléculaire :1697.93Cyclic somatostatin
CAS :Cyclic somatostatin (SRIF-14) is a cyclic tetradecapeptide regulating many endocrine and nervous system functions.Formule :C76H104N18O19S2Degré de pureté :96.86%Couleur et forme :PowderMasse moléculaire :1637.88Somatostatin extrapure, 97%
CAS :Formule :C76H104N18O19S2Degré de pureté :min. 97%Couleur et forme :White to off-white, PowderMasse moléculaire :1637.88Somatostatin (Human, Ovine, Porcine, Rat, Mouse)
CAS :<p>Somatostatin is a peptide hormone that has been found to inhibit pituitary growth hormone release as well as endocrine, pancreatic and GI secretions. It is widely expressed throughout the body for example in the gastrointestinal (GI) tract, hypothalamus, pancreas and the central nervous system. In the central nervous system somatostatin plays a role in neurotransmission modification and it has also demonstrated to be effective against a number of cancers such as squamous carcinoma. This product contains disulfide bonds between Cys3-Cys14 and is available as a 0.5mg vial.</p>Formule :C76H10N18O19S2Degré de pureté :Min. 95%Masse moléculaire :1,637.9 g/molSomatostatin
CAS :<p>Somatostatin is a peptide hormone that is produced by the hypothalamus and inhibits the release of growth hormones, stimulates the release of insulin from the pancreas, and inhibits the release of glucagon from the pancreas. Somatostatin also has biological properties that inhibit neuronal death in combination therapy groups. It has been shown to have cell factor activity which may contribute to its antitumor activity. Somatostatin also has pro-apoptotic properties in vitro assays at physiological levels, making it an excellent target for cancer therapy.</p>Formule :C76H104N18O19S2Degré de pureté :Min. 95%Masse moléculaire :1,637.9 g/molSomatostatin
CAS :<p>Somatostatin is a polypeptide hormone that is produced by the body to inhibit the release of other hormones in the body. It has also been used to treat diseases such as carcinoid syndrome, intestinal disorders, and diabetes mellitus type I. Somatostatin binds to somatostatin receptors on cells, which leads to inhibition of cell growth and secretion of hormones. Somatostatin has been shown to block basic protein synthesis and energy metabolism in rat liver cells. Its receptor activity is mediated by binding with signal peptide sequences and response elements.</p>Formule :C76H104N18O19S2Degré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :1,637.88 g/molCyclic Somatostatin
CAS :Formule :C76H104N18O19S2Degré de pureté :97%Couleur et forme :LiquidMasse moléculaire :1637.8781599999995











